Cabozantinib fails as first-line maintenance therapy in urothelial cancer
- 5 August 2022
- conference paper
- conference paper
- Published by Medicom Medische Uitgeverij BV in Medicom Conference Report ASCO 2022
Abstract
No abstract availableThis publication has 1 reference indexed in Scilit:
- Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial CarcinomaThe New England Journal of Medicine, 2020